98%
921
2 minutes
20
Upon stimulation with angiogenic factors, vascular endothelial cells (ECs) secrete a negative-feedback regulator of angiogenesis, vasohibin-1 (VASH1). Because VASH1 lacks a classical signal sequence, it is not clear how ECs secrete VASH1. We isolated a small vasohibin-binding protein (SVBP) composed of 66 amino acids. The level of Svbp mRNA was relatively high in the bone marrow, spleen and testes of mice. In cultured ECs, Vash1 mRNA was induced by VEGF, and Svbp mRNA was expressed constitutively. The interaction between VASH1 and SVBP was confirmed using the BIAcore system and immunoprecipitation analysis. Immunocytochemical analysis revealed that SVBP colocalized with VASH1 in ECs. In polarized epithelial cells, SVBP accumulated on the apical side, whereas VASH1 was present throughout the cells and partially colocalized with SVBP. Transfection of SVBP enhanced VASH1 secretion, whereas knockdown of endogenous SVBP markedly reduced VASH1 secretion. SVBP increased the solubility of VASH1 protein in detergent solution and inhibited the ubiquitylation of VASH1 protein. Moreover, co-transfection of SVBP significantly augmented the inhibitory effect of VASH1 on EC migration. These results indicate that SVBP acts as a secretory chaperone for VASH1 and contributes to the anti-angiogenic activity of VASH1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1242/jcs.067538 | DOI Listing |
Neuroscience
August 2025
Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan. Electronic address:
The vasohibin 1 (Vash1) and vasohibin 2 (Vash2) genes, known for their role in regulating angiogenesis, are also implicated in various cellular processes, including ferroptosis, a form of programmed cell death. However, the relationship between the endogenous Vash1 and Vash2 gene and ferroptosis in ischemic stroke was unknown. In this study, we investigated the function of the endogenous vasohibin genes in ferroptosis in a transient middle cerebral artery occlusion mice model.
View Article and Find Full Text PDFFEBS Lett
July 2025
Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Heart failure with preserved ejection fraction (HFpEF) is characterized by diastolic dysfunction, yet its molecular basis remains unclear. Here, we identified detyrosinated α-tubulin as a key cause of mitochondrial dysfunction and impaired mitophagy in HFpEF. In a SAUNA-induced HFpEF mouse model, elevated vasohibin-1 (VASH1) expression was associated with increased detyrosinated α-tubulin.
View Article and Find Full Text PDFJ Med Chem
August 2025
IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier 34293, France.
The development of small molecule inhibitors targeting the set of microtubules' post-translational modifications, also known as the "tubulin code", remains an underexplored area in medicinal chemistry. The recent discovery of the VASH1 and VASH2 enzymes, which are responsible for tubulin detyrosination─a modification associated with neurodegeneration and cancer─prompted us to develop new molecules that inhibit their activity. In this study, we conducted the first QSAR analysis of VASH proteases.
View Article and Find Full Text PDFJ Obstet Gynaecol Res
August 2025
Umraniye Training and Research Hospital, Department of Obstetrics and Gynecology, Maternal-Fetal Unit, Istanbul, Turkey.
Aim: To explore the potential role of first-trimester serum levels of vasohibin-1, cardiotropin-1, and endocan in predicting the development of preeclampsia.
Methods: In this prospective case-control study, blood samples were collected from 1054 pregnant women during the first-trimester screening test. The preeclampsia group consisted of 43 pregnant women who developed preeclampsia, while the control group included 129 pregnant women selected from a pool of 777 women whose pregnancies progressed without complications.
Arq Bras Oftalmol
July 2025
Department of Medical Biochemistry and Clinical Biochemistry, (Firat Hormones Research Group), Medical School, Firat University, Elazig, Turkiye.
Purpose: This pilot study was conducted to investigate the presence of various bioactive compounds (copeptin, asprosin, and salusins) in the blood and tears of patients with glaucoma.
Methods: A total of 83 subjects, including 28 patients with open-angle glaucoma, 28 patients with ocular hypertension, and 27 control volunteers, were enrolled in this study. The levels of salusin-α, salusin-β, copeptin, and asprosin in tears and venous blood samples were measured by enzyme linked immunosorbent assay (ELISA).